AMRX
USDAmneal Pharmaceuticals Inc. Class A Common Stock
即時價格
價格圖表
關鍵指標
市場指標
開盤
$11.010
最高
$11.400
最低
$10.940
交易量
3.47M
公司基本面
市值
3.6B
行業
Drug Manufacturers - Specialty & Generic
國家
United States
交易統計
平均交易量
1.66M
交易所
NMS
貨幣
USD
52週範圍
相關新聞
Piper Sandler Reiterates Overweight on Amneal Pharmaceuticals, Raises Price Target to $13
Piper Sandler analyst David Amsellem reiterates Amneal Pharmaceuticals with a Overweight and raises the price target from $11 to $13.
Amneal Reports Third Quarter 2025 Financial Results
‒ Q3 2025 Net Revenue of $785 million; GAAP Net Income of $2 million; Diluted Income per Share of $0.01 ‒‒ Adjusted EBITDA of $160 million; Adjusted Diluted EPS of $0.17 ‒‒ Updated 2025 Full Year Guidance ‒ BRIDGEWATER,
Amneal Receives U.S. FDA Tentative Approval for Beclomethasone Dipropionate HFA Inhalation Aerosol
BRIDGEWATER, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. ("Amneal" or the "Company") today announced that the U.S. Food and Drug Administration (FDA) has tentatively approved the Company's
